Found: 11
Select item for more details and to access through your institution.
Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 12, p. 3861, doi. 10.3390/jcm9123861
- By:
- Publication type:
- Article
Correction to: Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 1, p. 160, doi. 10.1007/s10637-019-00845-w
- By:
- Publication type:
- Article
Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.657743
- By:
- Publication type:
- Article
Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1740, doi. 10.3390/cancers14071740
- By:
- Publication type:
- Article
Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer.
- Published in:
- Radiation Oncology, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13014-023-02286-5
- By:
- Publication type:
- Article
Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 9, p. 2028
- By:
- Publication type:
- Article
Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 6, p. 801, doi. 10.1007/s11523-021-00848-9
- By:
- Publication type:
- Article
[<sup>18</sup>F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patients: long term prognosis assessment and clinical management proposal.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 12, p. 3696, doi. 10.1007/s00259-024-06794-8
- By:
- Publication type:
- Article
Prognostic value of immunotherapy-induced organ inflammation assessed on <sup>18</sup>FDG PET in patients with metastatic non-small cell lung cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 11, p. 3878, doi. 10.1007/s00259-022-05788-8
- By:
- Publication type:
- Article